中国科学技术大学 fubinqing--Home-- Binqing Fu, Xiaoling Xu, Haiming Wei. Why tocilizumab could be an effective treatment for severe COVID 19? Journal of translational medicine, (2020) Apr 14; 18(1):164.

傅斌清 ( Special Professor )
My personal homepage http://faculty.ustc.edu.cn/fubinqing/zh_CN/index.htm
Special Professor

Paper Publications Current position： Home >> Scientific Research >> Paper Publications

Binqing Fu, Xiaoling Xu, Haiming Wei. Why tocilizumab could be an effective treatment for severe COVID 19? Journal of translational medicine, (2020) Apr 14; 18(1):164.

Hits:
Translation or Not:no
Date of Publication:2021-09-03

Pre One: Zhou YG#, Fu BQ#, Zheng XH#, Wang DS, Zhao CC, Qi YJ, Sun R, Tian ZG, Xu XL, Wei HM: Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients. National Science Review, 2020, nwaa041, doi.org/10.1093/nsr/nwaa041

Next One: Subsets of human natural killer cells and their regulatory effects